NRC Health Financial Ratios — NRC Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	26.18	32.85	30.12	27.55	25.33	29.98	30.77	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	11.77	15.01	14.67	15.09	13.67	16.5	18.51	25.53	29.63	30.53	25.75	22.08	24.49	19.44	8.68
Return on Capital (%)	20.04	25.85	24.98	24.4	23.19	28.22	29.89	610.29	-53.41	-86.53	-192.45	-522.92	1,969.44	103.21	27.36
Return on Invested Capital (%)	17.67	22.09	20.73	20.55	19.3	24.38	25.74	41.16	55.21	46.73	37.5	33.57	34.5	29.63	15.64
Gross Margin (%)	62.16	58.97	58.05	57.79	56.41	58.33	58.26	60.25	63.72	63.09	64.62	62.36	62.3	60.2	61.88
EBITDA Margin (%)	31.41	31.73	30.82	32.48	29.86	32.38	33.01	34.04	37.95	37.25	38.28	34.19	30.92	28.81	21.99
Operating Margin (%)	24.73	26.29	26.79	28.63	25.84	28.52	29.11	29.47	33.63	31.62	33.98	30.71	26.95	24.6	16.44
Incremental Operating Margin (%)	39.44	37.39	33.83	55.87	-52.74	67.46	36.97	49.65	93.54	-16.83	55.37	-103.13	217.47	87.88	222.29
Pretax Margin (%)	23.97	25.7	26.45	28.42	26.73	28.67	29.16	29	31.66	31.11	32.86	28.25	26.9	22.85	12.99
Profit Margin (%)	15.26	17.44	16.72	18.37	17.21	18.76	19.52	25.1	25.32	27.96	25.32	20.98	20.84	17.32	8.44
Net Income to Common Margin (%)	15.26	17.44	16.72	18.37	17.21	18.76	19.52	25.1	25.32	27.96	25.32	20.98	20.84	17.32	8.44
Effective Tax Rate (%)	36.32	32.15	36.77	35.37	35.64	34.56	33.08	13.43	20.02	10.15	22.94	25.73	22.5	24.19	35
Dvd Payout Ratio (%)	51.12	115.23	13.83	- -	57.09	139.16	73.52	56.11	96.58	28.23	24.45	65.92	117.42	46.21	94.64
Sustainable Growth Rate (%)	12.79	-5	25.96	27.55	10.87	-11.74	8.15	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	15	13	10	8	6	4	1	38	34	31	27	22	37	63	79
ST Debt	2	13	2	2	2	3	1	4	4	4	4	4	7	5	4
LT Debt	13	- -	8	6	3	1	- -	34	30	27	22	18	29	58	75
Total Debt/EBITDA	0.63	0.47	0.37	0.26	0.19	0.1	0.03	0.93	0.7	0.62	0.47	0.43	0.8	1.52	2.62
Net Debt/EBITDA	0.27	0.15	-0.41	-1	-1.19	-0.83	-0.87	0.61	0.43	-0.08	-0.49	-0.05	0.65	1.42	2.48
Total Debt/EBIT	0.8	0.56	0.42	0.29	0.22	0.12	0.03	1.07	0.79	0.73	0.53	0.48	0.92	1.78	3.5
Net Debt/EBIT	0.34	0.18	-0.47	-1.13	-1.38	-0.94	-0.98	0.7	0.48	-0.1	-0.55	-0.06	0.75	1.66	3.32
EBITDA to Interest Expense	37.84	50.68	71.88	105.25	138.89	186.43	473.23	26.93	23.23	27.38	33.98	42.86	53.3	15.88	6.35
EBITDA-CapEx/Interest Expense	33.37	46.34	66.37	97.08	125.53	165.52	414.48	22.98	21	25.19	30.67	34.73	34.99	9.93	4.1
EBIT to Interest Expense	29.79	41.99	62.48	92.77	120.21	164.19	417.3	23.31	20.58	23.25	30.16	38.5	46.46	13.56	4.74
Interest Expense	1	1	- -	- -	- -	- -	- -	2	2	2	2	1	1	3	5
Common Equity/Total Assets	46.69	44.71	52.27	56.92	51.03	59.31	60.95	-98.41	-84.32	-45.98	-22.9	-19.28	-24.91	-12.85	-12.8
Long-Term Debt/Equity (%)	23.31	0.4	11.24	6.54	4.5	1.03	- -	179.09	90.58	41.28	26.1	24.56	60.2	185.06	536.25
Long-Term Debt/Capital (%)	20.92	0.39	11.78	7.01	4.69	1.14	- -	-49.92	-50.37	-86.37	-233.57	-595.22	476.48	126.82	121.45
Long-Term Debt/Total Assets (%)	12.86	0.22	7.26	4.43	2.61	0.71	- -	31.64	26.92	19.9	14.14	13.56	24.07	43.68	55.62
Total Debt/Equity (%)	26.84	22.49	14.55	9.37	7.83	4.37	1.26	198.31	103.89	47.59	31.11	30.79	74.93	200.37	564.94
Total Debt/Capital (%)	24.08	22.2	15.24	10.03	8.17	4.82	1.45	-55.27	-57.77	-99.58	-278.45	-746.33	593.11	137.31	127.95
Total Debt/Total Assets (%)	14.81	12.76	9.4	6.35	4.54	3	0.89	35.03	30.87	22.94	16.85	17	29.96	47.29	58.6
Net Debt to Equity	11.53	7.31	-16.4	-36.44	-49.05	-35.6	-37.39	130.23	62.8	-6.35	-32.59	-3.95	61.34	186.84	535.35
Net Debt/Capital (%)	11.9	8.43	-25.35	-76.32	-125.49	-69.96	-76.5	-30.51	-28.42	6.24	43.53	10.16	-6,416.88	141.12	129.96
EBITDA	24	27	29	32	31	35	39	41	49	50	57	52	46	41	30
EBITDA-CapEx	21	25	26	30	28	31	34	35	44	46	51	42	30	26	20
Operating Income (Loss)	19	23	25	28	26	31	34	35	43	42	50	47	40	35	23

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.33	0.23	0.93	1.43	0.95	1.05	1.07	0.28	0.35	1.09	1.35	0.75	0.18	0.12	0.11
Current Ratio	0.91	0.67	1.54	1.9	1.25	1.49	1.62	0.6	0.76	1.71	1.82	1.31	0.67	0.55	0.55
Quick Ratio	0.83	0.61	1.46	1.81	1.21	1.44	1.54	0.54	0.66	1.57	1.7	1.2	0.53	0.43	0.43
CFO/Avg Current Liab	0.73	0.64	0.65	1.01	0.61	0.71	0.88	1	0.96	1.16	1.29	0.98	1.09	0.96	0.73
Common Equity/Total Assets	46.69	44.71	52.27	56.92	51.03	59.31	60.95	-98.41	-84.32	-45.98	-22.9	-19.28	-24.91	-12.85	-12.8
Long-Term Debt/Equity (%)	23.31	0.4	11.24	6.54	4.5	1.03	- -	179.09	90.58	41.28	26.1	24.56	60.2	185.06	536.25
Long-Term Debt/Capital (%)	20.92	0.39	11.78	7.01	4.69	1.14	- -	-49.92	-50.37	-86.37	-233.57	-595.22	476.48	126.82	121.45
Long-Term Debt/Total Assets (%)	12.86	0.22	7.26	4.43	2.61	0.71	- -	31.64	26.92	19.9	14.14	13.56	24.07	43.68	55.62
Total Debt/Equity (%)	26.84	22.49	14.55	9.37	7.83	4.37	1.26	198.31	103.89	47.59	31.11	30.79	74.93	200.37	564.94
Total Debt/Capital (%)	24.08	22.2	15.24	10.03	8.17	4.82	1.45	-55.27	-57.77	-99.58	-278.45	-746.33	593.11	137.31	127.95
Total Debt/Total Assets (%)	14.81	12.76	9.4	6.35	4.54	3	0.89	35.03	30.87	22.94	16.85	17	29.96	47.29	58.6
CFO/Total Liabilities	40.96	44.18	49.11	62.73	40.66	70.98	75.36	44.8	52.6	58.8	64.19	62.07	51.87	34.2	21.88
CFO/CapEx	6.57	8.15	8.83	10.51	7.45	6.76	5.83	6.67	8.79	10.2	8.4	3.69	2.42	2.24	2.47
Altman's Z-Score	5.59	5.77	12.5	9.84	8.75	12.85	20.04	8.32	15.14	12.2	11.99	13.74	11.7	5.86	4.61

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	7.44	7.42	7.99	10.32	11.42	10.58	9.16	8.96	10.86	10.43	10.7	10.75	11.07	12.21	12.4
Days Sales Outstanding	49.04	49.22	45.65	35.38	31.96	34.49	39.85	40.76	33.6	35	34.11	33.94	32.97	29.89	29.44
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	32.97	66.04	82.21	56.23	61.79	66.1	72.27	78.9	49.09	41.44	34.46	36.85	45.65	45.64	44.33
Accounts Payable Turnover Days	11.07	5.53	4.44	6.49	5.91	5.52	5.05	4.63	7.44	8.81	10.59	9.9	8	8	8.23
Cash Conversion Cycle	37.97	43.69	41.21	28.88	26.06	28.97	34.8	36.13	26.16	26.19	23.52	24.04	24.97	21.89	21.2
Inventory to Cash Days	49.04	49.22	45.65	35.38	31.96	34.49	39.85	40.76	33.6	35	34.11	33.94	32.97	29.89	29.44
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	454	339	388	460	906	1,033	1,636	1,076	1,056	930	971	418	420
- Cash & Cash Equivalents	8	8	22	40	42	33	35	13	14	35	54	25	7	4	4
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	15	13	10	8	6	4	1	38	34	31	27	22	37	63	79
Enterprise Value	7	4	442	307	352	431	872	1,058	1,657	1,072	1,028	927	1,001	477	495
Total Capital	62	57	69	82	71	75	79	-68	-59	-31	-10	-3	6	46	62
Total Debt/Capital (%)	24.08	22.2	15.24	10.03	8.17	4.82	1.45	-55.27	-57.77	-99.58	-278.45	-746.33	593.11	137.31	127.95
Total Debt / EV	2.18	2.85	0.02	0.03	0.02	0.01	- -	0.04	0.02	0.03	0.03	0.02	0.04	0.13	0.16
EV/Sales	0.09	0.05	4.78	3.11	3.44	3.94	7.42	8.84	12.94	8.04	6.95	6.11	6.74	3.33	3.6
EV/EBITDA	0.29	0.16	15.5	9.57	11.52	12.16	22.48	25.97	34.1	21.59	18.14	17.88	21.78	11.56	16.38
EV/EBIT	0.36	0.2	17.83	10.86	13.31	13.81	25.49	29.99	38.49	25.44	20.44	19.91	24.99	13.54	21.91
EV/Cash Flow to Firm	0.36	0.23	22.61	11.64	15.99	15.97	30.99	25.71	38.9	25.36	21.58	24.94	25.81	13.02	16.76
EV/Free Cash Flow to Firm	0.31	0.2	20.33	10.64	14.1	13.92	26.46	22.45	35.06	23.18	19.34	19.72	18.34	9.16	12.3
Diluted Market Cap	- -	- -	463	344	393	467	941	1,071	1,691	1,099	1,065	934	976	419	420
Diluted Enterprise Value	7	4	452	312	357	438	907	1,096	1,712	1,094	1,037	932	1,006	477	495
EV per Share	1.02	0.66	18.34	12.68	14.54	17.79	35.92	39.06	66.77	42.59	40.43	37.19	40.78	20.11	22.12
TTM Sales	76	86	93	99	102	109	118	120	128	133	148	152	149	143	137
TTM EBITDA	24	27	29	32	31	35	39	41	49	50	57	52	46	41	30
TTM Operating Income	19	23	25	28	26	31	34	35	43	42	50	47	40	35	23
TTM Cash Flow to Firm	19	19	20	26	22	27	28	41	43	42	48	37	39	37	30
TTM Free Cash Flow to Firm	22	22	22	29	25	31	33	47	47	46	53	47	55	52	40

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	21.54	12	15.83	15.17	28.6	23.37	37.12	24.62	20.53	20.27	18.11	8.36	11.31
EV/EBIT	0.36	0.2	17.83	10.86	13.31	13.81	25.49	29.99	38.49	25.44	20.44	19.91	24.99	13.54	21.91
Enterprise Value	7	4	442	307	352	431	872	1,058	1,657	1,072	1,028	927	1,001	477	495
Low Price	- -	- -	12.36	12.41	10.72	12.53	16.5	26.35	36.51	34	39.27	30.93	37.19	16.74	9.76
EV/Sales	0.09	0.05	4.78	3.11	3.44	3.94	7.42	8.84	12.94	8.04	6.95	6.11	6.74	3.33	3.6
EV/EBITDA	0.29	0.16	15.5	9.57	11.52	12.16	22.48	25.97	34.1	21.59	18.14	17.88	21.78	11.56	16.38
Price/Earnings	- -	- -	29.32	18.68	22.06	22.43	39.48	34.39	50.48	28.88	28.17	29.23	31.35	16.87	36.22
Price/Earnings Average	- -	- -	26.68	20.08	19.52	17.99	29.11	32.63	40.05	37.06	32.22	29.59	34.39	26.62	28.76
Price/Earnings High	- -	- -	33.2	26.15	23.96	23.61	44.44	38.63	52.72	48.2	37.77	33.67	37.72	40.34	37.41
Price/Earnings Low	- -	- -	19.26	16.57	14.74	14.79	17.46	23.76	27.95	22.97	26.65	24.24	29.47	16.01	18.83
Price/Book Value	- -	- -	7.82	4.6	5.95	6.43	11.67	-9.72	-17.53	-17.54	-29.25	-36.96	-31.83	-24.55	-24.33
Price/Book Value Average	- -	- -	7.11	4.95	5.26	5.16	8.61	-9.22	-13.91	-22.51	-33.46	-37.4	-34.92	-38.74	-19.32
Price/Book Value High	- -	- -	8.85	6.44	6.46	6.77	13.14	-10.92	-18.3	-29.28	-39.22	-42.57	-38.3	-58.7	-25.14
Price/Book Value Low	- -	- -	5.13	4.08	3.97	4.24	5.16	-6.71	-9.71	-13.95	-27.67	-30.65	-29.92	-23.3	-12.65
Price/Tangible Book Value	- -	- -	48.7	14.25	30.7	21.09	30.96	-25.29	-61.11	190.45	48.12	105.54	-68.71	-11.15	-7.72
Price/Tangible Book Value Average	- -	- -	44.32	15.31	27.17	16.92	22.83	-24	-48.48	244.41	55.04	106.82	-75.38	-17.6	-6.13
Price/Tangible Book Value High	- -	- -	55.15	19.95	33.35	22.2	34.85	-28.42	-63.81	317.85	64.53	121.55	-82.67	-26.67	-7.98
Price/Tangible Book Value Low	- -	- -	31.99	12.64	20.52	13.91	13.7	-17.47	-33.83	151.47	45.52	87.52	-64.59	-10.59	-4.02
Price/Sales	- -	- -	4.9	3.43	3.8	4.21	7.71	8.63	12.78	8.07	7.13	6.13	6.53	2.92	3.06
Price/Sales Average	- -	- -	4.46	3.69	3.36	3.37	5.68	8.19	10.14	10.36	8.16	6.21	7.17	4.61	2.43
Price/Sales High	- -	- -	5.55	4.8	4.12	4.43	8.67	9.7	13.35	13.47	9.57	7.06	7.86	6.99	3.16
Price/Sales Low	- -	- -	3.22	3.04	2.54	2.77	3.41	5.96	7.08	6.42	6.75	5.09	6.14	2.77	1.59
Price/Cash Flow	- -	- -	23.51	12.94	17.75	17.14	32.24	25.93	39.98	26.48	22.78	25.63	25.47	12.08	15.88
Price/Cash Flow Average	- -	- -	21.39	13.92	15.71	13.75	23.77	24.61	31.72	33.98	26.05	25.94	27.95	19.05	12.61
Price/Cash Flow High	- -	- -	26.62	18.12	19.28	18.04	36.3	29.13	41.75	44.19	30.54	29.52	30.65	28.87	16.41
Price/Cash Flow Low	- -	- -	15.44	11.48	11.86	11.3	14.26	17.91	22.14	21.06	21.54	21.26	23.95	11.46	8.26
Price/Free Cash Flow Average	- -	- -	19.6	12.9	14.01	12.17	21.08	22.18	29.44	31.6	23.48	20.52	19.87	13.2	8.98
Price/Free Cash Flow High	- -	- -	24.39	16.81	17.19	15.96	32.19	26.26	38.76	41.09	27.52	23.35	21.79	20	11.69
Price/Free Cash Flow Low	- -	- -	14.15	10.65	10.58	10	12.65	16.15	20.55	19.58	19.42	16.81	17.03	7.94	5.88
EV/Sales Average	0.09	0.05	4.34	3.37	3	3.11	5.39	8.4	10.3	10.33	7.97	6.19	7.37	5.02	2.97
EV/Sales High	0.09	0.05	5.43	4.48	3.77	4.16	8.39	9.91	13.51	13.44	9.38	7.05	8.06	7.4	3.7
EV/Sales Low	0.09	0.05	3.09	2.72	2.18	2.51	3.12	6.17	7.24	6.39	6.56	5.07	6.34	3.18	2.14
EV/EBITDA Average	0.29	0.16	14.07	10.36	10.06	9.59	16.34	24.68	27.14	27.73	20.82	18.1	23.84	17.43	13.52
EV/EBITDA High	0.29	0.16	17.61	13.8	12.62	12.84	25.41	29.1	35.6	36.09	24.49	20.61	26.08	25.68	16.84
EV/EBITDA Low	0.29	0.16	10.04	8.38	7.31	7.74	9.46	18.13	19.07	17.15	17.13	14.82	20.52	11.05	9.71
EV/EBIT Average	0.36	0.2	16.19	11.76	11.63	10.89	18.53	28.5	30.64	32.67	23.46	20.15	27.35	20.41	18.08
EV/EBIT High	0.36	0.2	20.25	15.66	14.58	14.58	28.82	33.61	40.18	42.52	27.6	22.94	29.92	30.07	22.53
EV/EBIT Low	0.36	0.2	11.55	9.51	8.44	8.78	10.73	20.94	21.53	20.21	19.31	16.5	23.54	12.94	12.99
Last Price	- -	- -	18.82	13.99	16.04	19	37.3	38.14	65.94	42.75	41.52	37.3	39.56	17.64	18.77
High Price	- -	- -	21.31	19.59	17.42	20	41.99	42.85	68.86	71.35	55.67	42.96	47.6	42.18	19.39
Enterprise Value Average	7	4	401	333	307	340	634	1,005	1,318	1,377	1,179	938	1,095	718	409
Enterprise Value High	7	4	502	443	386	455	986	1,186	1,729	1,792	1,387	1,068	1,198	1,058	509
Enterprise Value Low	7	4	287	269	223	274	367	739	926	852	971	768	943	455	293

Shares Outstanding	3	3	24	24	24	24	24	25	25	25	25	25	24	23	23
Diluted Weighted Avg Shares	7	7	25	25	25	25	25	28	26	26	26	25	25	24	22
Basic Weighted Avg Shares	7	7	24	24	24	24	24	27	25	25	25	25	25	24	22
Revenue per Share	11.36	12.76	3.84	4.08	4.23	4.52	4.84	4.42	5.16	5.3	5.82	6.08	6.05	6.04	6.14
EBITDA per Share	3.57	4.05	1.18	1.32	1.26	1.46	1.6	1.5	1.96	1.97	2.23	2.08	1.87	1.74	1.35
Operating Income per Share	2.81	3.35	1.03	1.17	1.09	1.29	1.41	1.3	1.73	1.67	1.98	1.87	1.63	1.48	1.01
Basic EPS, GAAP	1.73	2.22	0.64	0.75	0.73	0.85	0.94	1.11	1.31	1.48	1.47	1.28	1.26	1.05	0.52
Basic EPS from Cont Ops	1.73	2.22	0.64	0.75	0.73	0.85	0.94	1.11	1.31	1.48	1.47	1.28	1.26	1.05	0.52
Diluted EPS, GAAP	1.69	2.17	0.63	0.74	0.72	0.83	0.91	1.07	1.26	1.45	1.46	1.27	1.26	1.04	0.52
Diluted EPS from Cont Ops	1.69	2.17	0.63	0.74	0.72	0.83	0.91	1.07	1.26	1.45	1.46	1.27	1.26	1.04	0.52
Dividend per Share	0.89	2.56	0.09	- -	0.42	1.18	0.69	0.62	1.26	0.42	0.36	0.84	1.48	0.48	0.49
Cash Flow per Share	2.77	2.82	0.8	1.08	0.9	1.11	1.16	1.47	1.65	1.61	1.82	1.46	1.55	1.46	1.18
Free Cash Flow per Basic Share	2.35	2.48	0.71	0.98	0.78	0.94	0.96	1.25	1.46	1.46	1.61	1.06	0.91	0.81	0.7
Cash & Equivalents per Share	1.21	1.22	0.92	1.65	1.74	1.36	1.43	0.48	0.54	1.38	2.14	1	0.27	0.18	0.18
Book Value per Share	7.04	6.6	2.41	3.04	2.7	2.95	3.2	-3.92	-3.76	-2.44	-1.42	-1.01	-1.24	-0.72	-0.77
Tangible Book Value per Share	-1.39	-1.01	0.39	0.98	0.52	0.9	1.2	-1.51	-1.08	0.22	0.86	0.35	-0.58	-1.58	-2.43

NRC Health

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)